Business
Biotech Firm Abivax's Stock Plummets
Abivax, a French biotech company, saw its stock price drop by over 30% following an update on its bowel disease drug trial results. Investors reacted negatively to the latest data.
Coverage timeline — 1 article
CNBC
Shares of French biotech Abivax tumbled 32% after it reported fresh data on its lead asset.
2026-06-02 07:28 UTC